Roger M. Klein insider trades: Evoke Pharma (EVOK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roger reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | EVOK | ↓ Sell | 5,000 | $10.66 | $53K | By IRA | Nov 7, 2025 (1d) |
| Nov 6, 2025 | EVOK | ↓ Sell | 4,000 | $10.65 | $43K | By Krieger Charitable Trust | Nov 7, 2025 (1d) |
| Jun 14, 2023 | CHRA | ↑ Buy | 19,197 | $5.88 | $113K | Indirect | Jun 30, 2023 (16d) |
| Jun 13, 2023 | CHRA | ↑ Buy | 3,000 | $5.90 | $18K | Direct | Jun 30, 2023 (17d) |
| Jun 8, 2023 | CHRA | ↑ Buy | 13,329 | $5.80 | $77K | Indirect | Jun 30, 2023 (22d) |
| Jun 2, 2023 | CHRA | ↑ Buy | 600 | $5.84 | $4K | Indirect | Jun 30, 2023 (28d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Roger M. Klein's insider trades
Roger M. Klein is a 10% owner of Evoke Pharma (EVOK). Since Jun 2, 2023, Roger has reported 4 open-market purchases worth $212K and 2 sales worth $96K on SEC Form 4. In the last 12 months: 2 sales ($96K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVOK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.